Comparing Mobile-health Network Solutions (NASDAQ:MNDR) and SOPHiA GENETICS (NASDAQ:SOPH)

SOPHiA GENETICS (NASDAQ:SOPH) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Risk & Volatility

SOPHiA GENETICS has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, Mobile-health Network Solutions has a beta of -2.64, meaning that its stock price is 364% less volatile than the S&P 500.

Profitability

This table compares SOPHiA GENETICS and Mobile-health Network Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-41.13%	-37.75%	-18.75%
Mobile-health Network Solutions	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for SOPHiA GENETICS and Mobile-health Network Solutions, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1	0	2	0	2.33
Mobile-health Network Solutions	1	0	0	0	1.00

SOPHiA GENETICS presently has a consensus target price of $9.00, indicating a potential upside of 78.22%. Given SOPHiA GENETICS’s stronger consensus rating and higher probable upside, equities research analysts clearly believe SOPHiA GENETICS is more favorable than Mobile-health Network Solutions.

Valuation & Earnings

This table compares SOPHiA GENETICS and Mobile-health Network Solutions”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$65.17 million	5.24	-$62.49 million	($0.46)	-10.98
Mobile-health Network Solutions	$7.65 million	0.28	-$3.38 million	N/A	N/A

Mobile-health Network Solutions has lower revenue, but higher earnings than SOPHiA GENETICS.

Institutional & Insider Ownership

31.6% of SOPHiA GENETICS shares are held by institutional investors. 4.9% of SOPHiA GENETICS shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

SOPHiA GENETICS beats Mobile-health Network Solutions on 8 of the 12 factors compared between the two stocks.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.